KEYTRUDA®
Brand Name: KEYTRUDA®
Composition: Pembrolizumab Injection (100 mg / 4 mL)
Manufacturer: MSD
Product Description
Medical Info
Keytruda (Pembrolizumab) is a breakthrough prescription immunotherapy formulation indicated for intravenous infusion. As a highly targeted humanized monoclonal antibody, it works by blocking the PD-1 cellular pathway, effectively enabling the body’s own immune system to recognize, attack, and destroy specific cancer cells. Supplied as a single-dose vial containing 100 mg of pembrolizumab per 4 mL of solution, this advanced therapeutic agent is widely prescribed across oncology for treating advanced malignancies, including non-small cell lung cancer and melanoma. Administration requires precise clinical evaluation, strict professional supervision, and individualized dosage scheduling tailored to the patient.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
